Stay updated on Daratumumab Therapy for Refractory AL Amyloidosis Clinical Trial

Sign up to get notified when there's something new on the Daratumumab Therapy for Refractory AL Amyloidosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab Therapy for Refractory AL Amyloidosis Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T22:41:27.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the Phase II study of Daratumumab therapy for patients with refractory or relapsed AL amyloidosis. This change may reflect new information or developments in the treatment protocol for this medical condition.
    Difference
    0.1%
    Check dated 2024-06-06T14:43:35.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The webpage has been updated to include detailed eligibility criteria for participation in the study, specifying requirements such as age, health conditions, and prior treatments. Previously, no information was provided about the participation criteria for collaborators and investigators.
    Difference
    25%
    Check dated 2024-05-22T21:31:09.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    0.9%
    Check dated 2024-04-30T22:28:09.000Z thumbnail image

Stay in the know with updates to Daratumumab Therapy for Refractory AL Amyloidosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab Therapy for Refractory AL Amyloidosis Clinical Trial page.